President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for the popular obesity treatments Zepbound and Wegovy. Known as GLP-1 ...
The White House’s weight-loss drug briefing was halted after Novo Nordisk executive Gordon Findlay fainted on camera, ...
Oz acknowledged obesity isn't "a deficiency of GLP drugs" but called reducing costs "a belt-and-suspenders approach." ...
NDTV Profit on MSN
Watch: Pharma Executive Collapses Next To Trump During White House Event On Obesity Drug Price Cuts
C haos ensued at a White House event on Thursday after a pharmaceutical executive collapsed in the Oval Office during a press ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback